Cloxazolam
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Akton, Cloxam, Clozal, Elum, Olcadil, and Sepazon |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 65 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H14Cl2N2O2 |
| Molar mass | 349.21 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties. It is not widely used; as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan. In 2019, it has been retired from the Belgian market.
See also
External links
| 5-HT1AR agonists | |
|---|---|
| GABAAR PAMs |
|
|
Gabapentinoids |
|
| Antidepressants |
|
|
Sympatholytics |
|
| Others | |
| |